Literature DB >> 27895635

Molecular Characteristic and Virulence Gene Profiles of Community-Associated Methicillin-Resistant Staphylococcus aureus Isolates from Pediatric Patients in Shanghai, China.

Xing Wang1, Xia Li2, Wei Liu1, Weichun Huang1, Qihua Fu1, Min Li3.   

Abstract

Staphylococcus aureus is a globally important human pathogen, especially among children and immunocompromised patients. The emergence and spread of community-associated methicillin-resistant S. aureus (CA-MRSA) has become a serious public health problem worldwide. The aim of this study was to investigate the prevalence, molecular characteristics and virulence profiles of CA-MRSA infections from pediatric patients in a university hospital in Shanghai, China. A total of 80 CA-MRSA isolates were collected from July 2012 to December 2013 in Shanghai Children's Medical Center and analyzed by multilocus sequence typing, staphylococcus chromosomal cassette mec (SCCmec) typing, and spa typing. The detection of Panton-Valentine Leukocidin (pvl), superantigenic and exfoliative toxins, and adhesin genes was also performed. Overall, 16 distinct sequence types (STs) were identified among the 80 isolates. Among them, ST59 was found to be the most prevalent, followed by ST398 (11.3%, 9/80) and ST88 (8.8%, 7/80). SCCmec types IV and V were observed, at 60 and 40%, respectively. Thirty spa types were identified, spa t437 (23.8%) was the most predominant type. All 80 isolates exhibited carriage of at least four virulence genes. Thirty-four (42.5%, 34/80) isolates harbored ≥10 tested virulence genes. Adhesion genes were present in most of the MRSA isolates, including the following: icaA (100%), clfA (100%), sdrC (95%), and sdrE (63.8%). The prevalence of pvl gene was 20%, and multidrug resistance was observed in 36% of all strains. In addition, ST59-MRSA-IV with t437 accounted for 21.3% of occurrences, making it the most prevalent clone. Isolates that were carriers of toxin genes, and hla (100%) and hlg (87.5%) were the most frequent. In conclusion, simultaneous carriage of multiple virulence genes and genetically considerable diversity were very common among CA-MRSA from pediatric patients in Shanghai. ST59-MRSA-IV with t437 was still the most predominant type. The combination of virulence gene profiles and antibiotic resistance may help ST59 to be successfully spread among children.

Entities:  

Keywords:  MLST-genotyping; SCCmec typing; community-associated methicillin-resistant staphylococcus aureus; spa typing; virulence factors

Year:  2016        PMID: 27895635      PMCID: PMC5108810          DOI: 10.3389/fmicb.2016.01818

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Staphylococcus aureus is one of the most prevalent human pathogens, causing a broad variety of diseases ranging from mild skin and soft-tissue infections to severe systemic infections such as sepsis and necrotizing pneumonia (Lowy, 1998; Deresinski, 2005). Since methicillin-resistant S. aureus (MRSA) was first reported in the United Kingdom in 1961 (Monecke et al., 2011), it has become a particular public threat to human health. During the last 55 years, various hospital-associated MRSA (HA-MRSA) clones have disseminated worldwide, including Europe, United States, North Africa, the Middle East, and East Asia. Since the 1990s, community-associated MRSA (CA-MRSA) emerged as a serious health problem worldwide (David and Daum, 2010; DeLeo et al., 2010), first in communities and later in healthcare facilities. Compared to HA-MRSA strains, most CA-MRSA isolates that harbor SCCmec types IV or V, do not have multi-antibiotic resistance (except to β lactams), and many possess different exotoxin gene profiles (e.g., PVL genes; Dinges et al., 2000). However, another MRSA clone from animals (LA-MRSA) has emerged in humans exposed to livestock since 2005. Livestock-associated MRSA ST398, isolated from pigs and pig farmers has been reported in European countries and North America. For LA-MRSA, ST398 is the overwhelmingly dominant lineage in Europe, whereas ST9 predominates in most Asian countries (Fluit, 2012; Chuang and Huang, 2015). Currently, more than 20 genetic lineages have been reported to be associated with CA-MRSA worldwide (Witte, 2009; Mediavilla et al., 2012). The top five major lineages include ST1-IV (WA-1, USA400), ST8-IV (USA300), ST30-IV (South West Pacific clone), ST59-V (Taiwan clone), and ST80-IV (European clone). However, CA-MRSA strains were found to be continent-specific. For example, ST1 and ST8 clones are mostly found in the United States and Canada, whereas ST80 clones are mainly found in Europe. In China and several other Asian countries, ST59-IV and ST59-V are the most common CA-MRSA strains. The prevalence of CA-MRSA varies greatly and the occurrence rate of CA-MRSA infections ranges from <5 to >35% in different Asian countries (Chen and Huang, 2014). Prevalence is higher in children than in adults. Because of low immunity in children, once infected with CA-MRSA, the consequences are often very serious (Machuca et al., 2013). Although, CA-MRSA infection and transmission represent a major public health problem, there is limited information reported on CA-MRSA monitoring among children in China. The aim of this study was to investigate the prevalence, molecular characteristics and virulence profiles of CA-MRSA infections from pediatric patients in China and to determine whether the epidemiology could be affected by time.

Materials and methods

Bacterial isolates

From July 2012 to December 2013, a total of 80 sequential CA-MRSA isolates, which represent all the non-duplicate strains isolated during the study period, were collected from pediatric patients with local or systemic infections in a university hospital in Shanghai, China (Shanghai Children's Medical Center, affiliated with Shanghai Jiao Tong University; CLSI, 2012). Shanghai Children's Medical Center is one of the largest pediatric hospitals in China with 800 beds and ~3000 hospital admissions per day. MRSA isolates were confirmed by classic microbiological methods: Gram stain and catalase and coagulase activity on rabbit plasma. They were further identified by biochemical characterization using the Api-Staph test (bioMérieux, Lyon, France). CA-MRSA was defined as an MRSA isolate that was obtained either from an outpatient or an inpatient within 48 h of hospitalization, and without the patient having medical history of MRSA infection or colonization, admission to a healthcare facility, dialysis, surgery or insertion of indwelling devices in the past year. These isolates were recovered from several clinical sources, including the respiratory tract (sputum, pharynx swabs, and bronchial alveolar lavage fluid), skin and soft tissue (cutaneous abscess and wound secretion), cerebrospinal fluid, blood and urine (Klevens et al., 2007). All strains were stored at −70°C and grown overnight on sheep blood agar plates at 37°C. The Ethics Committee of Shanghai Children's Medical Center exempted this study from review because the present study focused on bacteria.

Antimicrobial susceptibility testing

The antibiotic susceptibility of all isolates in this study was performed using the bioMe'rieux VITEK2 system following manufacturer's instructions. Results were interpreted in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2012). The following 17 drugs were tested: cefazolin (CFZ), linezolid (LZD), ciprofloxacin (CIP), clindamycin (DA), erythromycin (E), trimethoprim-sulfamethoxazole (SXT), moxifloxacin (MOF), nitrofurantoin (FD), vancomycin (V), tetracycline (TET), penicillin (P), rifampicin (RF), levofloxacin (LVX), ampicillin (AMP), gentamicin (GM), quinupristin/dalfopristin (Q/D), and tigecycline (TGC). S. aureus ATCC 29213 was used as a quality control.

MLST analysis

Isolates were screened according to the protocol described (Enright and Spratt, 1999) on the S. aureus MLST website (http://saureus.mlst.net) to detect the following seven housekeeping genes (Aanensen and Spratt, 2005): carbamate kinase (arcC), shikimate dehydrogenase (aroE), glycerol kinase (glp), guanylate kinase (gmk), phosphate acetyltransferase (pta), triosephosphate isomerase (tpi), and acetyl coenzyme A acetyltransferase (yqiL). PCR amplicons of seven S. aureus housekeeping genes were obtained from chromosomal DNA. The sequences of the PCR products were compared with the existing alleles available from the MLST website, and the allelic number (sequence type, ST) was determined for each sequence. Clustering of related STs, which were defined as clonal complexes (CCs), was determined using eBURST (based on related STs).

SCCmec typing

The MRSA isolates were subjected to SCCmec typing as described by Kondo et al. (2007), which was based on a set of multiplex PCRs (M-PCRs) with 14 primers. SCCmec types I–V were assigned according to the combination of the cassette chromosome recombinase (ccr) type and mec class. MRSA isolates that could not be assigned to any expected type were defined as nontypable (NT).

Spa typing

In S. aureus, the polymorphic X region of staphylococcal protein A (spa) gene consists of a variable number of 24 bp repeat units (Shopsin et al., 1999) that allow isolates to be distinguished from one another. The spa typing was based on variations of the repeat units. Amplification and sequencing of the X region were performed as described previously by Koreen et al. (2004). The spa typing was assigned by submitting the data to the S. aureus spa type database (http://spaserver.ridom.de).

Virulence gene profiles

All MRSA isolates were screened for the following 22 staphylococcal virulence genes: the staphylococcal enterotoxin genes (sea, seb, sec, sed, see, seg, seh, sei, seq, sek), the toxic shock syndrome toxin (tsst), the arginine catabolic mobile gene (arcA), the exfoliative toxin genes (eta, etb), the PVL genes (lukF/S-PV; Lina et al., 1999), the hemolysin gene (hla, hlb, hlg), and the adhesin genes (clfA, icaA, sdrC, and sdrE) as previously described (Arvidson and Tegmark, 2001; Peacock et al., 2002; Bubeck Wardenburg et al., 2007).

Statistical analysis

Statistical analyses were performed using Stata software (version 10.1/SE, Stata Corp., College Station, TX, USA). We used the χ2 and Fisher's exact tests, as appropriate for analysis of categorical data. Statistical significance was set at P ≤ 0.05.

Results

Clinical features

Eighty MRSA isolates were obtained from patients 10 days to 11 years old with local or systemic infection and all the isolates were positive for the mecA genes. Among them, 52 patients (65%) were male. 61.3% (49/80) of the children were <1 year old and 18 were neonates (22.5%). From the clinical medical records, respiratory infection was the most frequently determined infection type caused by CA-MRSA; 82.5% (66/80) of the isolates were from the respiratory tract, and 5% (4/80) of the isolates were associated with bloodstream infection (BSI).

MLST, SCCmec, and spa typing

The evolutionary and genetic diversity of MRSA isolates within individual patients was analyzed by MLST (Table 1). There were 16 distinct STs identified within the 80 isolates, among which the most frequently represented was ST59 (45.0%, 36/80). It accounted for nearly one half of all MRSA isolates, followed by ST398 (11.3%, 9/80), ST88 (8.8%, 7/80), ST5 (7.5%, 6/80), ST630 (7.5%, 6/80), ST7 (3.8%, 3/80), ST338 (2.5%, 2/80), ST45 (2.5%, 2/80), ST9 (2.5%, 2/80). Among the remaining 7 STs (ST30, ST72, ST6, ST20, ST950, ST1507, ST121), each ST just had one isolate. This methodology revealed that the strains clustered by eBURST into 9 CCs (CC59, CC398, CC88, CC5, CC8, CC7, CC72, CC45, CC9) and 4 singletons (Figure 1), among which were CC59 with 38 isolates, CC398 with 9 isolates, CC88 with 7 isolates, CC5 with 7 isolates, CC8 with 6 isolates, CC7 with 3 isolates, CC72 with 2 isolates, CC45 with 2 isolates, and CC9 with 2 isolates. Sixteen isolates harboring pvl were distributed among 7 different STs, including ST59 (n = 9) and ST338 (n = 2), as well as ST398, ST88, ST30, ST20, and ST121 (one isolate each).
Table 1

Clonal complexes and the relationship among the molecular types of MRSA isolates from pediatric patients.

Clonal complex (CC)MLST (n,%)SCCmec type
spa TypeIVVNO.
CC59ST59 (36, 45.0%)t43714317
t44177
t31644
t17244
t16311
t175111
t352311
t888611
ST338 (2, 2.5%)t43722
CC398ST398 (9, 11.25%)t034246
t011112
t125011
CC88ST88 (7, 8.75%)t231044
t748022
t763711
CC5ST5 (6, 7.5%)t06233
t246011
t18711
t00211
ST950t89511
CC8ST630 (6, 7.5%)t4549145
NT11
CC7ST7 (3, 3.75%)t79622
t09111
CC45ST45 (2, 2.5%)t11611
t23011
CC72ST72t66411
ST1507t66411
CC9ST9 (2, 2.5%)t89922
ST30t01911
ST6t70111
ST20t16411
ST121t15911
Figure 1

Distribution of STs in the clonal complexes. The eBURST application of the MLST data from all of the isolates analyzed in this study. The purple numbers represent 16 STs which are found in 80 MRSA isolates. STs that are linked by a line belong to the same cluster. Circle sizes are proportional to the number of strains within the ST.

Clonal complexes and the relationship among the molecular types of MRSA isolates from pediatric patients. Distribution of STs in the clonal complexes. The eBURST application of the MLST data from all of the isolates analyzed in this study. The purple numbers represent 16 STs which are found in 80 MRSA isolates. STs that are linked by a line belong to the same cluster. Circle sizes are proportional to the number of strains within the ST. By SCCmec typing, only two types (types IV and V) were found among 80 MRSA isolates. The most common was type IV, which was found in 48 isolates (60%, 48/80), while type V was found in 32 isolates (40%, 32/80). The spa typing discriminated MRSA isolates into 30 spa types. Among them, spa t437 was the most predominant type (23.8%, 19/80), followed by t441 (8.8%, 7/80), t034 (7.5%, 6/80), t4549 (6.3%, 5/80), t172 (5%, 4/80), t316 (5%, 4/80), and t2310 (5%, 4/80). Each of the remaining spa types was represented in <3 isolates. There was a strong association observed between specific ST and spa types. The ST59 genotype was associated primarily with spa t437 (47.2%, 17/36) and spa t441 (19.4%, 7/36), and less frequently with six types: t316, t172, t163, t3523, t8886, t1751. The ST398 genotype was associated mainly with spa t034 (6/9) and spa t011 (2/9). The antimicrobial resistance profiles of 80 MRSA isolates according to MLST are listed in Table 2. All the strains were resistant to cefazolin, penicillin, and ampicillin, but susceptible to vancomycin, linezolid, nitrofurantoin, quinupristin/dalfopristin, and tigecycline. The majority were resistant to clindamycin (80%) and erythromycin (82.5%), however, they were susceptible to most of the antibiotics tested. The resistance rates to other antibiotics tested were 8.8% to ciprofloxacin, 10% to trimethoprim-sulfamethoxazole, 3.8% to moxifloxacin, 32.5% to tetracycline, 2.5% to rifampicin, 5% to levofloxacin, and 3.8% to gentamicin. The resistance profiles of MRSA isolates differed by their STs. For the ST59 strains, the most prevalent antibiotic group contains clindamycin, erythromycin, and tetracycline, while ST9 strains were more resistant to more antibiotics including ciprofloxacin, clindamycin, erythromycin, trimethoprim-sulfamethoxazole and tetracycline.
Table 2

Antimicrobial susceptibility profiles among the molecular types of MRSA isolates from pediatric patients.

Molecular typeIsolatesa (n)CFZa (%)LZDa (%)CIPa (%)DAa (%)Ea (%)SXTa (%)MOFa (%)FDa (%)Va (%)TETa (%)Pa (%)RDa (%)LEVa (%)AMPa (%)GMa (%)Q/Da (%)TGCa (%)
ST59361000094.497.2000036.110000100000
ST39891000088.988.9000011.110000100000
ST887100014.357.171.414.314.30042.910014.314.310014.300
ST56100033.383.383.35016.70033.3100033.310016.700
ST6306100016.783.383.3016.70016.710016.716.710016.700
ST73100033.366.766.766.700033.310000100000
ST4521000050500000010000100000
ST92100010010010010000010010000100000
ST338210000100100000010010000100000
ST72110000000000010000100000
ST950110000000000010000100000
ST30110000000000010000100000
ST61100001001000000010000100000
ST20110000000000010000100000
ST12111000000000010010000100000
ST1507110000000000010000100000
Total8010008.758082.5103.750032.51002.551003.7500

cefazolin (CFZ), linezolid (LZD), ciprofloxacin (CIP), clindamycin (DA), erythromycin (E), trimethoprim-sulfamethoxazole (SXT), moxifloxacin (MOF), nitrofurantoin (FD), vancomycin (V), tetracycline (TET), penicillin (P), rifampicin (RF), levofloxacin (LVX), ampicillin (AMP), gentamicin (GM), quinupristin/dalfopristin (Q/D) and tigecycline (TGC).

Antimicrobial susceptibility profiles among the molecular types of MRSA isolates from pediatric patients. cefazolin (CFZ), linezolid (LZD), ciprofloxacin (CIP), clindamycin (DA), erythromycin (E), trimethoprim-sulfamethoxazole (SXT), moxifloxacin (MOF), nitrofurantoin (FD), vancomycin (V), tetracycline (TET), penicillin (P), rifampicin (RF), levofloxacin (LVX), ampicillin (AMP), gentamicin (GM), quinupristin/dalfopristin (Q/D) and tigecycline (TGC). The distribution of 19 putative virulence genes differed among the 80 MRSA strains according to MLST (Table 3). All virulence genes except eta, etb, and arcA genes were identified within multiple isolates, and all isolates exhibited carriage of at least 4 virulence genes. Thirty-four (42.5%, 34/80) isolates harbored ≥10 tested virulence genes, among which were 1 isolate with 13 genes, 3 isolates with 12 genes, 14 isolates with 11 genes, and 16 isolates with 10 genes.
Table 3

Virulence gene distribution among the molecular types of MRSA isolates from pediatric patients.

Molecular typeIsolates (n)icaAclfAsdrCsdrEhlahlbhlgpvltsstseasebsecsedseesegsehseisekseq
ST593610010097.283.310083.391.7255.627.888.905.62.82.88.32.886.186.1
ST398910010010033.310033.366.711.10011.111.10000000
ST88710010010071.410014.385.714.30000010000000
ST5610010083.366.710033.383.305033.316.733.316.7010016.710000
ST630610010010033.3100100100000000000000
ST7310010010033.310033.310000033.30066.700033.333.3
ST45210010010050100050050005000100010000
ST92100100100010010010005000000100010000
ST3382100100100100100100100100005005000005050
ST7211001001000100000000000100010000
ST9501100100010010001000000000100010000
ST30110010010001000100100000000100010000
ST611001001000100010000000000100000
ST201100100010010001001000000010000000
ST1211100100100010010010010000100000100010000
ST1507110010010010010001000000000100010000
Total801001009563.81006087.5208.81546.35513.8206.32041.341.3
Virulence gene distribution among the molecular types of MRSA isolates from pediatric patients. Adhesion genes were present in most of the MRSA isolates; 100% carried the icaA and clfA genes, 95% harbored sdrC, 63.8% carried sdrE. The most prevalent toxin genes detected were hla (100%), hlg (87.5%), hlb (60%), seb (46.3%), sek (41.3%), and seq (41.3%). The pvl gene was detected in 16 strains, which represented seven different STs, with ST59 being the most common.

Molecular characteristics of the prevalent clone ST59

In this study, ST59 (45.0%, 36/80) was found to be the most prevalent clone, which was associated primarily with spa t437 (44.7%, 17/36) and spa t441 (18.4%, 7/36). ST59 strains were more resistant to erythromycin (P = 0.002) and clindamycin (P = 0.004) but more susceptible to ciprofloxacin (P = 0.015) and trimethoprim-sulfamethoxazole (P = 0.007) than other STs (Table 4). In addition, non-ST59 strains were more often associated with multiple antibiotic-resistance profiles. They were also resistant to moxifloxacin, rifampicin, levofloxacin, and gentamicin, while ST59 did not have these profiles.
Table 4

Antimicrobial susceptibility profiles of ST59 and non-ST59 isolates.

ST59 (n = 36), Ra (%)Non-ST59 (n = 44), R (%)P- valueb
CFZ100100
LZD00
CIP015.9<0.05
DA94.468.1<0.01
E97.270.5<0.01
SXT018.2<0.01
MOF06.8>0.05
FD00
V00
TET36.129.5>0.05
P100100
RD04.5>0.05
LEV09.1>0.05
AMP100100
GM06.8>0.05
Q/D00
TGC00

R, Resistance.

The resistance rates of antimicrobials among ST59 were compared with those among non-ST59 isolates.

Antimicrobial susceptibility profiles of ST59 and non-ST59 isolates. R, Resistance. The resistance rates of antimicrobials among ST59 were compared with those among non-ST59 isolates. All isolates exhibited icaA, clfA, and hla genes. The frequency of carriage for hlb, sea, seb, sek, seq, or sdrE among ST59 isolates was significantly higher than that for non-ST59 isolates (P < 0.05; Table 5). Twenty-eight (77.8%) of 36 ST59 isolates harbored ≥10 tested virulence genes, which was significantly higher than that among non-ST59 isolates (13.6%, 6/44) (P < 0.05). However, there were no significant differences on the positive rate of pvl between ST59 and non-ST59 strains.
Table 5

Frequencies of virulence genes among ST59 and non-ST59 isolates.

Virulence genesST59 (n = 36)Non-ST59 (n = 44)P-valuea
icaA100100>0.05
clfA100100>0.05
sdrC97.293.2>0.05
sdrE83.347.7<0.01
hla100100>0.05
hlb83.340.9<0.01
hlg91.784.1>0.05
pvl2515.9>0.05
tsst5.611.4>0.05
sea27.84.5<0.01
seb88.911.4<0.01
sec09.1
sed5.64.5>0.05
see2.822.7<0.01
seg2.834.1<0.01
seh8.34.5>0.05
sei2.834.1<0.01
sek86.14.5<0.01
seq86.14.5<0.01

The positive rates of virulence genes among ST59 were compared with those among non-ST59 isolates.

Frequencies of virulence genes among ST59 and non-ST59 isolates. The positive rates of virulence genes among ST59 were compared with those among non-ST59 isolates.

Discussion

Recently, CA-MRSA infection and transmission have become major public health problems worldwide, particularly among children and immunocompromised patients. Given the dangerous consequences of MRSA infection on pediatric patients, it is necessary to understand the prevalence, molecular characteristics and virulence profiles of these isolates in order to take effective measures to control infection and transmission in the affected communities. Our data suggested that ST59-MRSA-IV and ST59-MRSA-V with t437 were still the most predominant clones among all of the clinical MRSA isolates in Shanghai. During recent years, CA-MRSA infections have been found worldwide and the major pandemic clones are usually related to specific geographical locations (Mediavilla et al., 2012; Li et al., 2016). For instance, the ST1 and ST8 clone in the USA and Canada, the ST30 clone in Australia, the ST80 clone in Europe, the ST59 clone in the Asia-Pacific region, including Taiwan and Australia. These five clones comprise most of the CA-MRSA worldwide. In China, previous studies of the most common genotypes revealed that ST59-MRSA-IV (and its single locus variant ST338-MRSA-IV) was the major lineage accounting for up to two-thirds of isolates and the most common spa type was t437 (Geng et al., 2010). Similar to these findings, the predominant types of MRSA isolates in our study were ST59-MRSA-IV and ST59-MRSA-V with t437. The ST59 MRSA clone was also prevalent in Taiwan, Hong Kong, Vietnam, Japan, and Australia (Chuang and Huang, 2013). Based on these finding, ST59 has become a successful clone with potential for clonal expansion. However, the CA-MRSA ST59 clone identified in mainland China might differ from that identified in Taiwan (Chen and Huang, 2005). Most PVL-positive CA-MRSA ST59 clones in Taiwan belong to SCCmec VT, while CA-MRSA ST59 clones in our study belong to SCCmec IV or SCCmec V. This observation supports the notion that ST59-MSSA lineages may provide a stable genetic environment for integration of SCCmec in favor of their infection and transmission in the community. In addition, the most prevalent multiresistant antibiotic profiles of ST59 strains included erythromycin, tetracycline, clindamycin, penicillin, and ampicillin. These findings may be explained by the selective pressure of antibiotic abuse in the Chinese community (Aires de Sousa et al., 2003). In this study, ST398-MRSA- IV/V with three spa types, t034, t011, and t1250, was found to be the second most predominant type. This MRSA clone, first observed among pig and pig farmers in the Netherlands in 2003, then found in Austria, Germany, and Denmark (Fluit, 2012). Due to the presence of a restriction/methylation system, the strains are non-typeable with standard PFGE using SmaI digestion. ST398 is a typical livestock-associated type (Graveland et al., 2011), previous studies show that patients carrying this type are usually in contact with a major animal reservoir of these MRSA, mostly pigs (Yan et al., 2014). In our study, six patients (66.7%, 6/9) were <6 months and the others (33.3%, 3/9) were <3 years. From their medical history, they were no directly in contact with animal hosts, suggesting that there is a potential risk of MRSA introduction from the animal reservoirs into communities or hospitals with humans as the vector. ST9 is the dominant livestock-associated lineage in Asia (Chuang and Huang, 2015), there were two ST9 strains found in our study and no evidence to support them as LA-MRSA clones. In China, there is still very limited information on the occurrence of LA-MRSA infection, probably due to lack of diagnostic facilities and transmission information. Identifying risk factors and transmission routes is very important. Based on available studies, the pathogenicity for S. aureus largely depends on the carriage of a battery of virulence factors associated with adhesion, invasion, persistence, the evasion/destruction of host defenses, tissue invasion/penetration and toxin-mediated disease (Moreillon et al., 1995; Bubeck Wardenburg et al., 2007; Diep and Otto, 2008; Yu et al., 2011). Of those, previous studies reported some virulence genes are found virtually in all S. aureus, while others are linked to specific molecular types. However, in our study, most of the MRSA isolates were found to harbor the hla, hlg, seb, and sek genes, but no association was found between molecular types and toxin genes. Compared to other STs, ST59 clones harbor more toxin genes and 77.8% of ST59 isolates harbored ≥10 tested virulence genes, which may help ST59 become successfully spread in China. In addition, the adhesion genes (clfA, icaA, sdrC, and sdrE) were evaluated in this study (Josefsson et al., 1998). All strains carried the icaA and clfA genes, 95% harbored sdrC, and 63.8% carried sdrE. The high percentage is consistent with the fact that these genes are ubiquitously carried by MRSA strains that belong to different lineages and that these genes have been reported to play a key role in the process of bacterial pathogenicity. In conclusion, simultaneous carriage of multiple virulence genes and considerable genetic diversity were very common among CA-MRSA from pediatric patients in Shanghai. ST59-MRSA-IV with t437 was still the most predominant type. In an era of increasing CA-MRSA, appropriate measures need to be taken to prevent further morbidity and mortality worldwide. This effort should take into account the molecular characteristics of CA-MRSA strains.

Author contributions

ML, QF, and XW designed the studies and obtained funding. XW, XL, WH, and WL performed the experiments and/or analyzed the data; ML, XW, and XL wrote the manuscript.

Funding

This study was supported by the National Natural Science Foundation of China (grants 81301392) and the Training Program for Outstanding Young Teachers in Higher Education Institutions (ZZjdyx13132), the Training Program for Clinical Medical Young Talents in Shanghai, Visiting Scholar Research Program and SCMC-EPT Program to XW.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  33 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Prevalence of virulence genes among invasive and colonising Staphylococcus aureus isolates.

Authors:  F Yu; L Yang; J Pan; C Chen; J Du; Q Li; J Huang; X Zhang; L Wang
Journal:  J Hosp Infect       Date:  2010-10-27       Impact factor: 3.926

Review 3.  Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?

Authors:  W Witte
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

Review 4.  Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA).

Authors:  José R Mediavilla; Liang Chen; Barun Mathema; Barry N Kreiswirth
Journal:  Curr Opin Microbiol       Date:  2012-10-05       Impact factor: 7.934

Review 5.  Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans.

Authors:  Haitske Graveland; Birgitta Duim; Engeline van Duijkeren; Dick Heederik; Jaap A Wagenaar
Journal:  Int J Med Microbiol       Date:  2011-10-07       Impact factor: 3.473

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus.

Authors:  Elisabet Josefsson; Kirk W McCrea; Deirdre Ni Eidhin; David O'Connell; Jos Cox; Magnus Hook; Timothy J Foster
Journal:  Microbiology (Reading)       Date:  1998-12       Impact factor: 2.777

Review 8.  The role of virulence determinants in community-associated MRSA pathogenesis.

Authors:  Binh An Diep; Michael Otto
Journal:  Trends Microbiol       Date:  2008-06-26       Impact factor: 17.079

9.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.

Authors:  Stefan Monecke; Geoffrey Coombs; Anna C Shore; David C Coleman; Patrick Akpaka; Michael Borg; Henry Chow; Margaret Ip; Lutz Jatzwauk; Daniel Jonas; Kristina Kadlec; Angela Kearns; Frederic Laurent; Frances G O'Brien; Julie Pearson; Antje Ruppelt; Stefan Schwarz; Elizabeth Scicluna; Peter Slickers; Hui-Leen Tan; Stefan Weber; Ralf Ehricht
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

View more
  22 in total

1.  Survey of Staphylococcus aureus in a general pediatric population and focus on isolates with three clinically relevant toxin-encoding genes.

Authors:  Anne Filleron; Sarah Beauregard-Birba; Thibault Mura; Fabien Aujoulat; Anne Laure Michon; Michel Rodière; Tu Anh Tran; Eric Jeziorski; Hélène Marchandin
Journal:  World J Pediatr       Date:  2018-02-13       Impact factor: 2.764

2.  Molecular Characteristics, Antimicrobial Resistance and Virulence Gene Profiles of Staphylococcus aureus Isolates from Wuhan, Central China.

Authors:  Yu Fu; Mengyuan Xiong; Xuehan Li; Junying Zhou; Xiao Xiao; Fang Fang; Xiaohuan Cheng; Yingbang Le; Yirong Li
Journal:  Infect Drug Resist       Date:  2020-06-30       Impact factor: 4.003

3.  Multiresistant ST59-SCCmec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children.

Authors:  Xin Yang; Suyun Qian; Kaihu Yao; Lijuan Wang; Yingchao Liu; Fang Dong; Wenqi Song; Jinghui Zhen; Wei Zhou; Hong Xu; Hongyan Zheng; Wenting Li
Journal:  BMC Infect Dis       Date:  2017-11-25       Impact factor: 3.090

4.  Molecular Characteristics of Community-Associated Staphylococcus aureus Isolates From Pediatric Patients With Bloodstream Infections Between 2012 and 2017 in Shanghai, China.

Authors:  Xing Wang; Qian Liu; He Zhang; Xia Li; Weichun Huang; Qihua Fu; Min Li
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

5.  Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012-2017.

Authors:  Haiying Peng; Dengtao Liu; Yuhua Ma; Wei Gao
Journal:  Sci Rep       Date:  2018-12-17       Impact factor: 4.379

6.  A molecular epidemiological study of methicillin-resistant and methicillin-susceptible Staphylococcus aureus contamination in the airport environment.

Authors:  Zhiyao Chen; Changlin Han; Xiaobin Huang; Yangqun Liu; Dan Guo; Xiaohua Ye
Journal:  Infect Drug Resist       Date:  2018-11-20       Impact factor: 4.003

7.  Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China.

Authors:  Yingjian Liang; Changli Tu; Cuiyan Tan; Mohamed Abd El-Gawad El-Sayed Ahmed; Min Dai; Yong Xia; Yan Liu; Lan-Lan Zhong; Cong Shen; Guanping Chen; Guo-Bao Tian; Jing Liu; Xiaobin Zheng
Journal:  Infect Drug Resist       Date:  2019-02-25       Impact factor: 4.003

8.  Community-associated Staphylococcus aureus PVL+ ST22 predominates in skin and soft tissue infections in Beijing, China.

Authors:  Nan Xiao; Jianghui Yang; Ning Duan; Binghuai Lu; Lijun Wang
Journal:  Infect Drug Resist       Date:  2019-08-12       Impact factor: 4.003

9.  Contribution of Staphylococcal Enterotoxin B to Staphylococcus aureus Systemic Infection.

Authors:  Justin S Bae; Fei Da; Ryan Liu; Lei He; Huiying Lv; Emilie L Fisher; Govindarajan Rajagopalan; Min Li; Gordon Y C Cheung; Michael Otto
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

10.  Prevalence, resistance pattern, and molecular characterization of Staphylococcus aureus isolates from healthy animals and sick populations in Henan Province, China.

Authors:  Baoguang Liu; Huarun Sun; Yushan Pan; Yajun Zhai; Tian Cai; Xiaoling Yuan; Yanling Gao; Dandan He; Jianhua Liu; Li Yuan; Gongzheng Hu
Journal:  Gut Pathog       Date:  2018-07-17       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.